HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On the interaction of fluorophore-encapsulating PEGylated lecithin liposomes with hamster and human platelets.

Abstract
Polyethylene glycol (PEG)-grafted phosphatidylcholine liposomes are used as drug carriers due to their low immunogenicity and prolonged circulation time. The interaction between sterically stabilized lecithin liposomes and platelets has not been investigated before, and deserves to be subjected to scrutiny inasmuch as the uptake of liposomes by platelets could be detrimental for drug delivery and primary hemostasis. Consequently, the interaction between resting and convulxin-activated hamster and human platelets and calcein- or 5,6-carboxyfluorescein-encapsulating PEGylated liposomes composed of distearoyl- and dipalmitoyl phosphatidylcholine and PEG-derivatized distearoyl phosphatidylethanolamine was investigated by flow cytometry, confocal microscopy, and a glass capillary thrombosis model. Fluorescently labeled liposomes of the same composition were subsequently assayed in vivo after 15 and 45 min of systemic circulation. Neither resting nor activated hamster and human platelets interacted with liposomes at 0.70 mM lipid concentration. An absence of any interaction was corroborated in the in vivo experiments. Alternatively, flow cytometry assays evinced that human platelets interact with liposomes at lipid concentrations of >or=1.35 mM. These interactions were more profound for activated platelets than resting platelets. We conclude that the use of PEGylated lecithin liposomes at lipid concentrations of <1.35 mM has no detrimental impact on liposomal drug delivery based on PEGylated lecithin liposomes, but that these drug carriers may be associated with a reduced targeting efficacy or compromised primary hemostatic system when used at concentrations of >or=1.35 mM. In contrast, these drug carriers may become valuable in thrombosis- and drug delivery-related research and applications at concentrations of >or=1.35 mM.
AuthorsMichal Heger, Isabelle I Salles, Wiebe van Vuure, Irene H L Hamelers, Anton I P M de Kroon, Hans Deckmyn, Johan F Beek
JournalMicrovascular research (Microvasc Res) Vol. 78 Issue 1 Pg. 57-66 (Jun 2009) ISSN: 1095-9319 [Electronic] United States
PMID19281828 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Crotalid Venoms
  • Drug Carriers
  • Fluoresceins
  • Fluorescent Dyes
  • Lecithins
  • Lectins, C-Type
  • Liposomes
  • Phosphatidylcholines
  • convulxin
  • Polyethylene Glycols
  • 5,6-dicarboxyfluorescein
  • fluorexon
Topics
  • Animals
  • Blood Platelets (metabolism)
  • Cricetinae
  • Crotalid Venoms (pharmacology)
  • Drug Carriers
  • Drug Delivery Systems
  • Fluoresceins (metabolism)
  • Fluorescent Dyes (metabolism)
  • Humans
  • Lecithins (chemistry)
  • Lectins, C-Type
  • Liposomes (chemistry, metabolism)
  • Models, Cardiovascular
  • Particle Size
  • Phosphatidylcholines (chemistry)
  • Polyethylene Glycols (chemistry)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: